Sensorion Receives European Medicines Agency Agreement on the Pediatric Investigation Plan (PIP) for Arazasetron (SENS-401) in Two Indications

98

MONTPELLIER, France–(BUSINESS WIRE)–Sensorion receives European Medicines Agency agreement on the Pediatric Investigation Plan (PIP) for Arazasetron (SENS-401) in two indications….

 

 

http://www.businesswire.com/news/home/20190627005932/en/Sensorion-Receives-European-Medicines-Agency-Agreement-Pediatric